Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Design.

Related Articles

Evaluation of New Drugs for Asthma and COPD: Endpoints, Biomarkers and Clinical Trial Design.

Handb Exp Pharmacol. 2016 Nov 13;

Authors: Singh D

Abstract
There remains a considerable need to develop novel therapies for patients with asthma and chronic obstructive pulmonary disease (COPD). The greatest challenge at the moment is measuring the effects of novel anti-inflammatory drugs, as these drugs often cause only small effects on lung function. Measurements that demonstrate the pharmacological and clinical effects of these drugs are needed. Furthermore, we now recognise that only subgroups of patients are likely to respond to these novel drugs, so using biomarkers to determine the clinical phenotype most suitable for such therapies is important. An endotype is a subtype of a (clinical) condition defined by a distinct pathophysiological mechanism. An endotype-driven approach may be more helpful in drug development, enabling drugs to be targeted specifically towards specific biological mechanisms rather than clinical characteristics. This requires the development of biomarkers to define endotypes and/or to measure drug effects. This newer approach should continue alongside efforts to optimise the measurement of clinical endpoints, including patient-reported outcome measurements, required by drug regulatory authorities.

PMID: 27838852 [PubMed – as supplied by publisher]

View full post on pubmed: asthma

Health, environmental tracker could head off asthma attacks without drugs – FierceMedicalDevices (press release) (registration)


NDTV

Health, environmental tracker could head off asthma attacks without drugs
FierceMedicalDevices (press release) (registration)
Currently, asthma treatment involves avoiding irritants and taking medication to relieve symptoms. Researchers at North Carolina State University have created a wearable system that more concretely monitors potential environmental irritants and could …
New Wearable Device Could Predict, Prevent Asthma AttacksNDTV
Wearable system, new devices aim to predict, prevent asthma attacksWRAL Tech Wire
NC State Scientists Develop Wearable System To Predict, Prevent Asthma AttacksLung Disease News

all 6 news articles »

View full post on asthma – Google News

Yates fails drugs test using asthma inhaler – Eyewitness News


Eyewitness News

Yates fails drugs test using asthma inhaler
Eyewitness News
MELBOURNE – British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said on Friday. The Bury-born …
Simon Yates fails drugs test after 'using asthma inhaler' to plunge British Cycling deeper into crisisTelegraph.co.uk
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC News
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News

all 43 news articles »

View full post on asthma – Google News

Simon Yates fails drugs test after ‘using asthma inhaler’ to plunge British Cycling deeper into crisis – Telegraph.co.uk


Telegraph.co.uk

Simon Yates fails drugs test after 'using asthma inhaler' to plunge British Cycling deeper into crisis
Telegraph.co.uk
A disastrous week got worse for British Cycling last night after it emerged that Simon Yates, the former points race world champion and a contender for a spot on the GB road team at Rio de Janeiro this summer, failed an in-competition drugs test
Yates fails drugs test using asthma inhaler: teamReuters
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC Sport
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Daily Mail –The Guardian
all 41 news articles »

View full post on asthma – Google News

Yates fails drugs test using asthma inhaler: team – Reuters


BBC News

Yates fails drugs test using asthma inhaler: team
Reuters
LONDON British rider Simon Yates, a strong contender to make Team GB's Olympic cycling squad, has failed a drugs test due to an "administrative error" over the use of an asthma inhaler, his team Orica-GreenEDGE said on Friday. The Bury-born 23-year-old …
Simon Yates: British cyclist fails drug test 'after asthma inhaler error'BBC News
British cyclist Simon Yates fails drug test 'after asthma inhaler error'ITV News
Cycling-Yates fails drugs test using asthma inhaler – teamDaily Mail

all 33 news articles »

View full post on asthma – Google News

Local Doctor’s Study Examines Whether Allergy & Asthma Drugs Stunt Growth In Kids – CBS Local


CBS Local

Local Doctor's Study Examines Whether Allergy & Asthma Drugs Stunt Growth In Kids
CBS Local
“Up until now, we've never really known what combination therapy does to the growth of children,” Dr. David Skoner, an allergist at Allegheny General Hospital, says. This allergist's research says yes. “The results of our study shows that the effect is

View full post on asthma – Google News

Asthma Treatment Drugs Market In China Growth & Trends: Radiant Insights, Inc – Medgadget.com (blog)

Asthma Treatment Drugs Market In China Growth & Trends: Radiant Insights, Inc
Medgadget.com (blog)
This study focuses on China's Asthma Treatment Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer …

and more »

View full post on asthma – Google News

United States Preventive Asthma Drugs Industry 2015 Market Research Report by ReportBazzar – Medgadget.com (blog)

United States Preventive Asthma Drugs Industry 2015 Market Research Report by ReportBazzar
Medgadget.com (blog)
The Preventive Asthma Drugs market analysis is provided for the United States markets including development trends, competitive landscape analysis, and key regions development status. Development policies and plans are discussed as well as …

and more »

View full post on asthma – Google News